Difficulty: Medium
Average Score: 94%
Practice
Select the hypocholesterolemic drug which interferes with intestinal absorption of bile salts and cholesterol, and secondarily increases cholesterol turnover in the liver
Correct answer
B
Rationale
The correct answer is B) Cholestyramine. Cholestyramine is a bile acid sequestrant that works by binding to bile salts in the intestines, preventing their reabsorption. This action leads to increased excretion of bile salts in the feces, which in turn stimulates the liver to use cholesterol to synthesize more bile salts, thus reducing the overall cholesterol levels in the body.
A) Clofibrate is a fibric acid derivative that primarily works by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha) to increase lipoprotein lipase activity and decrease triglyceride levels. It does not interfere with intestinal absorption of bile salts and cholesterol.
C) Lovastatin is a statin drug that inhibits HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. It does not interfere with intestinal absorption of bile salts and cholesterol but instead reduces cholesterol production.
D) Bezafibrate is another fibric acid derivative similar to clofibrate, which also works through PPAR-alpha activation to lower triglycerides and increase HDL cholesterol levels. It does not interfere with intestinal absorption of bile salts and cholesterol.
Educationally, understanding the mechanism of action of drugs used to manage cholesterol levels is crucial for healthcare professionals. Knowing how each drug interacts with the body allows for informed decision-making when selecting the most appropriate drug for a patient based on their unique needs and health conditions. This knowledge also helps in monitoring and managing potential side effects and drug interactions effectively.
A) Clofibrate is a fibric acid derivative that primarily works by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha) to increase lipoprotein lipase activity and decrease triglyceride levels. It does not interfere with intestinal absorption of bile salts and cholesterol.
C) Lovastatin is a statin drug that inhibits HMG-CoA reductase, an enzyme involved in cholesterol synthesis in the liver. It does not interfere with intestinal absorption of bile salts and cholesterol but instead reduces cholesterol production.
D) Bezafibrate is another fibric acid derivative similar to clofibrate, which also works through PPAR-alpha activation to lower triglycerides and increase HDL cholesterol levels. It does not interfere with intestinal absorption of bile salts and cholesterol.
Educationally, understanding the mechanism of action of drugs used to manage cholesterol levels is crucial for healthcare professionals. Knowing how each drug interacts with the body allows for informed decision-making when selecting the most appropriate drug for a patient based on their unique needs and health conditions. This knowledge also helps in monitoring and managing potential side effects and drug interactions effectively.